BioHybrid Solutions LLC (BHS) is a Carnegie Mellon University spin-off, focused on next-generation protein-polymer biotherapeutics as alternatives to PEGylation.  A fast-growing company with a network of committed partners and collaborators working to deliver the next generation of biotherapeutics.

Biotechnology

BioHybrid Solutions

Brook Bankes-Polk

Anthony Manning

Krzysztof Matyjaszewski

Antonina Simakova

The Science and Research team at BioHybrid Solutions LLC focuses on the development, analysis, and optimization of next-generation protein-polymer biotherapeutics. This team conducts cutting-edge research, performs rigorous analytical testing, and collaborates closely with partners to innovate alternative solutions to PEGylation, driving the company's biotherapeutic advancements.

��

Science and Research

About

Team members

Other teams at BioHybrid Solutions

Administrative and Management Team

Leadership Team

��������